Image of white heart outline on a blue hash background with a red line at the bottom

Welcome to the Home of Heart Recovery

Learn more about achieving heart recovery in cardiogenic shock and high-risk revascularization at TCT 2022

The FDA has granted Impella® its highest level of approval as a safe and effective therapy for high-risk PCI, cardiogenic shock and right heart failure.

  • 1,200+

    Peer-reviewed clinical studies have published on Impella, including the PROTECT II randomized controlled trial

  • 13

    Clinical society guidelines include Impella heart pumps

  • 235,000+

    Patients have been treated with Impella heart pumps

 

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Jonathan Hill, MD, discusses influential trials in high-risk PCI that are shaping the future of ischemic heart failure therapy.

 

Ejection Fraction Improvement Following High-Risk PCI

Impella-supported high-risk PCI leads to a significant 29% relative improvement in LVEF 90 days after the procedure1

Portrait of a doctor in a white coat speaking to a patient

For Interventional Cardiologists

Treat high-risk PCI, cardiogenic shock and right heart failure patients

Portrait of a surgeon in the operating room

For Cardiac and Vascular Surgeons

Escalate, stabilize and recover native organs with minimally-invasive surgical techniques

Portrait of a female nurse with a group of nurses blurred out in the background

For Nurses

Use calculators, watch quick skills videos and learn patient management best practices

An image of a young doctor in a white coat with colleagues in the background at a table

For Fellows

Advance your knowledge and develop skills to treat complex PCI patients

For Referring Providers

Are you caring for patients with heart disease? Learn more about how Impella heart pumps work, the benefits of Protected PCI with Impella and explore patient identification resources. 

Native Heart and Lung Recovery

White illustration of the hospital with a red cross

Conditions & Therapies

Access education, clinical evidence and practice support for Protected PCI, AMI cardiogenic shock, right heart failure, surgical applications and severe lung failure.

White illustration of the hands holding a red cross

Products & Services

Learn about the latest technology and how that technology may best support your patient.

White illustration of a screen showing graphs

Education & Resources

Abiomed provides a comprehensive training program for health care providers.

Subscribe to receive the latest clinical data and priority access to resources.

References

  1. Wollmuth, J., Patel, M. et al. (2022). JSCAI, 100350. https://doi.org/10.1016/j.jscai.2022.100350

NPS-1309